Clinical trials
Phase 2 Attention Deficit Disorder with Hyperactivity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
127 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 4 |
| 2004 | 8 |
| 2005 | 11 |
| 2006 | 9 |
| 2007 | 12 |
| 2008 | 10 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 95 |
| Unknown status | 12 |
| Terminated | 9 |
| Recruiting | 7 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie (prior sponsor, Abbott) | 5 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 |
| Shire | 5 |
| New York State Psychiatric Institute | 4 |
| Supernus Pharmaceuticals, Inc. | 4 |
| Abbott | 3 |
| Alcobra Ltd. | 3 |
| Eli Lilly and Company | 3 |
| Pfizer | 3 |
| Aevi Genomic Medicine, LLC, a Cerecor company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 127 |
| Spasm | 7 |
| Substance-Related Disorders | 5 |
| Cocaine-Related Disorders | 4 |
| Autism Spectrum Disorder | 3 |
| Neurodevelopmental Disorders | 3 |
| Anxiety Disorders | 2 |
| Attention Deficit and Disruptive Behavior Disorders | 2 |
| Autistic Disorder | 2 |
| Brain Injuries, Traumatic | 2 |
Trials
Showing 26 to 50 of 127. Each trial links to its page on Pharma Observatory.
27 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.